Cerebrovascular risk factors and their time-dependent effects on stroke survival in the EMMA cohort study.


Journal

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
ISSN: 1414-431X
Titre abrégé: Braz J Med Biol Res
Pays: Brazil
ID NLM: 8112917

Informations de publication

Date de publication:
2023
Historique:
received: 09 06 2023
accepted: 09 08 2023
medline: 2 11 2023
pubmed: 4 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

To investigate the time-dependent effects of traditional risk factors on functional disability in all-cause mortality post-stroke, we evaluated data from a long-term stroke cohort. Baseline cerebrovascular risk factors (CVRF) and functionality at 1 and 6 months were evaluated in survivors from a prospective stroke cohort using the modified Rankin scale (m-RS), which classifies participants as improvement of disability, unchanged disability (at least moderate), and worsening disability. Cox regression models considering baseline risk factors, medication use, and functionality 6 months after stroke were fitted to identify their time-dependent effects up to 12 years of follow-up. Adjusted hazard ratios (HR) with 95% confidence intervals (CI) are presented. Among 632 survivors (median age 68, 54% male, 71% first-ever episode), age and functional disability (unchanged and worsening) 6 months after ischemic stroke had time-dependent effects on all-cause mortality risk up to 12 years of follow-up. The most impacting risk factors were unchanged (at least moderate) (HR, 2.99; 95%CI: 1.98-4.52) and worsening disability (HR, 2.85; 95%CI: 1.26-6.44), particularly in the first two years after a stroke event (Time 1: ≥6 mo to <2.5 y). Worsening disability also impacted mortality in the period from ≥2.5 to <7.5 years (Time 2) of follow-up (HR, 2.43 (95%CI: 1.03-5.73). Other baseline factors had a fixed high-risk effect on mortality during follow-up. Post-stroke and continuous medication use had a fixed protective effect on mortality. Functional disability was the main contributor with differential risks of mortality up to 12 years of follow-up.

Identifiants

pubmed: 37792780
pii: S0100-879X2023000100668
doi: 10.1590/1414-431X2023e12895
pmc: PMC10515500
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12895

Références

BMC Med Res Methodol. 2010 Mar 16;10:20
pubmed: 20233435
Am J Epidemiol. 2008 Feb 15;167(4):492-9
pubmed: 18056625
J Stroke Cerebrovasc Dis. 2016 Mar;25(3):618-25
pubmed: 26725125
J Neurosci Nurs. 2022 Apr 1;54(2):80-85
pubmed: 35175989
Stroke. 1989 Jun;20(6):828
pubmed: 2728057
Lancet Neurol. 2007 May;6(5):387-8; author reply 388-9
pubmed: 17434087
Kidney Int. 2008 Oct;74(8):994-7
pubmed: 18633346
Cad Saude Publica. 2012 Aug;28(8):1581-90
pubmed: 22892977
BMC Neurol. 2013 May 24;13:51
pubmed: 23706067
Stroke. 2019 Dec;50(12):3385-3392
pubmed: 31699020
Arch Phys Med Rehabil. 2017 Apr;98(4):722-729
pubmed: 27744024
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
PLoS One. 2014 Feb 04;9(2):e87884
pubmed: 24504327
Int J Stroke. 2022 Jan;17(1):48-58
pubmed: 33527882
Clin Neuropharmacol. 2011 Nov-Dec;34(6):234-40
pubmed: 21996648
Stroke. 2012 Mar;43(3):851-3
pubmed: 22135076
Ann Med. 2019 Feb;51(1):68-77
pubmed: 30592437
BMJ. 2010 Mar 12;340:b5087
pubmed: 20228141
Eur J Neurol. 2020 Mar;27(3):579-585
pubmed: 31721389
Int J Stroke. 2010 Aug;5(4):284-9
pubmed: 20636711
Cerebrovasc Dis. 2017;44(3-4):232-239
pubmed: 28848194

Auteurs

A C Goulart (AC)

Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil.

A C Varella (AC)

Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil.

G Tunes (G)

Instituto de Matemática e Estatística, Universidade de São Paulo, São Paulo, SP, Brasil.

A P Alencar (AP)

Instituto de Matemática e Estatística, Universidade de São Paulo, São Paulo, SP, Brasil.

I S Santos (IS)

Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil.
Instituto de Matemática e Estatística, Universidade de São Paulo, São Paulo, SP, Brasil.
Departamento de Medicina Interna, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.

C Romagnolli (C)

Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil.

T E Gooden (TE)

Institute for Applied Health Research, University of Birmingham, Birmingham, United Kingdom.

G N Thomas (GN)

Institute for Applied Health Research, University of Birmingham, Birmingham, United Kingdom.

G Y H Lip (GYH)

Institute for Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

R D Olmos (RD)

Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil.
Departamento de Medicina Interna, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.

P A Lotufo (PA)

Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil.
Departamento de Medicina Interna, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.

I M Bensenor (IM)

Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil.
Departamento de Medicina Interna, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH